Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer
Antineoplastic Combined Chemotherapy Protocols
Neoplasm Recurrence, Local
In this retrospective analysis, the prognosis of surgically resectable BRCA-associated PDAC is no different than that of sporadic PDAC from the same institution. The role of platinum-based adjuvant therapy in this setting requires prospective investigation.